Back to search

France· FR:65950064

SUNLENCA 464 mg, solution injectable

A lenacapavir product containing lénacapavir sodique, registered in France by GILEAD SCIENCES IRELAND UC (IRLANDE), on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC J05AX31

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedSUNLENCA 464 mg, solution injectableATCJ05AX31REGISTER NO.FR:65950064PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Lenacapavir is registered in 15 of 19 countries.

Countries holding a registration under ATC J05AX31 (lenacapavir), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Lenacapavir · ATC J05AX31

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lenacapavir costs, country by country.

Normalised to the WHO defined daily dose (0.19 g), the median price runs from $0.45 in France to $511.10 in Switzerland — a ×1140 gap.

  • France: $0.45 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Lenacapavir · price per daily dose (0.19 g)

USD · FX 28 Sept 2026

  • CH Switzerland$511.10
  • FR France$0.45
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
LÉNACAPAVIR SODIQUE
Manufacturer
GILEAD SCIENCES IRELAND UC (IRLANDE)
Country
France (FR)
ATC code
J05AX31
ATC class
Lenacapavir
Defined daily dose
0.19 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930258064
    2 flacon(s) en verre de 1,5 ml + 2 adaptateur(s) pour flacon + 2 seringue(s) + 2 aiguille(s)
    EUR 21.13

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lenacapavir in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lenacapavir products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Sunlenca, Yeytuo
  • Liechtenstein · Sunlenca, Yeytuo
  • Norway · Sunlenca, Yeytuo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ade9ce7e-56d1-411e-b1cc-2826d3a14162
GET /v1/drugs/ade9ce7e-56d1-411e-b1cc-2826d3a14162?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65950064",
  "date_amm": "2022-08-17",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/22/1671",
  "substance": "LÉNACAPAVIR SODIQUE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

See everything about lenacapavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.